Analysis of the state of medical and pharmaceutical care provided to cancer patients under the conditions of the healthcare system reform and martial law in the country

Organizing the provision of effective and affordable medical and pharmaceutical care to cancer patients is an important task in the development of national healthcare systems in any country. Aim: to analyze the state of medical and pharmaceutical care provided to cancer patients under the conditions of reforming the healthcare system and martial law in the country. Materials and methods. Historical, analytical-comparative, graphic, logical, organizational-economic, mathematical-statistical methods of analysis were used. Data from special literature, analytical materials presented on the website of the Ministry of Health and the National Health Service of Ukraine were studied. Results and discussion. It was found that in 2025, compared to 2024, the amounts of contracts concluded in Ukraine increased (by 5.5 % in chemotherapy and 7.27 % in radiology). It was proven that in the structure of contracts for servicing cancer patients in 2025, the dominant positions were occupied by healthcare institutions of municipal ownership (90.8 % – chemotherapy and 84.47 % – radiology). There was an uneven distribution of the number and amounts of contracts by regions of the country according to data of 2025. The highest values of these indicators were in the city of Kyiv, and the lowest in the Luhansk and Cherkasy regions; 17 regions of the country signed only one contract for radiological treatment and support of cancer patients. On average, one contract for the provision of chemotherapy services accounted for 24.39 million UAH, and for radiological treatment – 72.07 million UAH. In the case of chemotherapy, the conditional cost of one contract ranged from 7.17 million (Donetsk region) to 88.44 million UAH (Vinnytsia region), and for radiological treatment – from 21.27 million UAH (Kherson region) to 142.87 million UAH (Vinnytsia region). Under contracts for chemotherapy in 2024, compared to 2022, the amounts of contracts concluded increased by 18.78 % and the actual payment for services by 19.17 %, while for radiological treatment by 15.36 % and 18.99 %, respectively. It was determined that in 2023 the state purchased medicines for cancer patients in the amount of 2,136,971.5 thousand UAH, and in 2024 there was a significant decrease in this indicator (-9.36 %) to 1936975.2 thousand UAH. In the future, the state plans to increase spending on meeting the needs of cancer patients in these drugs. Conclusions. The resource support of the process of providing medical and pharmaceutical care to cancer patients in Ukraine has been studied. The presence of regional features of the development of this process, as well as positive trends in the increase of the amounts of contracts concluded and payment for the cost of providing care to cancer patients in Ukraine during 2022-2024, has been proven.